Irinotecan HCl for Injection

Product description

The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.

Strength: 40mg/2ml; 100mg/5ml.

CFDA approved. MA issued from US-FDA, Japanese PMDA.
Read more


Categories Finished Dosage FormsPowders; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Irinotecan HCl for Injection

Contact information




View all contact information